project id: TCGA-CHOL; case submitter id: TCGA-W5-AA2J; selected normal wgs: true; source center: 23; state: released; analyte type: DNA; analyte type id: D; spectrophotometer method: PicoGreen; age at index: 66; days to birth: -24140; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1946; age at diagnosis: 24140; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 916.0; icd 10 code: C22.1; last known disease status: not reported; morphology: 8160/3; primary diagnosis: Cholangiocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Intrahepatic bile duct; synchronous malignancy: No; tissue or organ of origin: Intrahepatic bile duct; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; weight: 30.0; days to collection: 411; initial weight: 280.0; sample id: dae39f08-74c6-4d03-a7e4-b1657758576f; sample submitter id: TCGA-W5-AA2J-01A; portion id: 32b7e71f-ca2b-4da0-aa86-02b7fa129cf5; portion submitter id: TCGA-W5-AA2J-01A-31; slide id: 28a3ecb6-8103-4083-8663-e06029b1819b; slide submitter id: TCGA-W5-AA2J-01A-03-TSC; percent lymphocyte infiltration: 8.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 3.0; percent normal cells: 0.0; percent stromal cells: 35.0; percent tumor cells: 65.0; percent tumor nuclei: 65.0; section location: TOP;